Please login to the form below
prescription drugs
This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.
Malthus’ orphans
Malthus came to mind this week as I read a valuable report from EvaluatePharma, which predicts that orphan drugs will capture no less than 20% of spend on prescription drugs by ... By and large, rare diseases and orphan drugs don’t lend themselves to
Latest news
-
Trump attempts The Art of the Deal with pharma
The plan seeks to increase competition, improve negotiation and create incentives to lower list prices of prescription drugs and out-of-pocket costs for consumers. ... controls and therefore pay less for drugs than Americans, while US companies invest in
-
Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report
Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report. ... That assertion ties in with its new report on worldwide prescription drug sales, which says that drugs for orphan diseases will outperform the overall pharma market,
-
Novartis plans digital therapeutics for schizophrenia and MS
Novartis plans digital therapeutics for schizophrenia and MS. Will work with Pear Therapeutics on a prescription software range. ... Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient
-
Not in my backyard
Not in my backyard. Let’s be honest: the notion that you can import prescription drugs from one country at a cheaper price and pass those savings on to consumers in ... And if 40% of US prescriptions flow through Canada, the branded prescription drug
-
Millennials’ disappointing medicine habits
The UK has an ‘under-informed’youth when it comes to prescription medicines, according to a new patient behaviour survey from the IPA’s Healthcare Group.
More from news
Approximately 2 fully matching, plus 174 partially matching documents found.
Latest Intelligence
-
US health reforms
In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs
-
Re-awakening the emotion in healthcare communications
phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the
-
Market access in Europe: balancing access and affordability
The accompanying figure summarises the measures that target spending on prescription drugs. ... Governments have typically begun by exploring opportunities to negotiate lower prices for orphan drugs.
-
Deal Watch September 2016
India's Sun Pharmaceutical has partnered with Mitsubishi Tanabe Pharma to distribute and market 14 prescription drugs in Japan that Sun recently acquired from Novartis. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex,
-
Market access improvements in Turkey
Almost the entire pharmaceutical market is made up of prescription medicines (93.8%) with 87% reimbursed. ... While welcoming the promise of a slight acceleration of review time with high priority medicines, industry is disappointed that orphan drugs and
More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest appointments
-
Keith Webber leaves FDA for Perrigo
Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs. ... This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.
-
Genzyme’s Richard Moscicki joins FDA
prescription-only drugs available in the US.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
How to build an online medical information service that resonates with your customers
However, as an increasing number of drugs have come off patent, there is a growing need for clinical and scientific medical information.Now more and more pharmaceutical companies are investing in ... 1. Understand that global regulation and compliance
-
How to design patient services with social media within the ABPI code guidelines
When designing digital services and informational materials for prescription drugs or services, there are unique considerations that must be taken around how that information is accessed and used. ... The code explains how use of social media to discuss
-
PEGASUS JOINS ASHFIELD HEALTHCARE COMMUNICATIONS
Sharp is also a world leader in ’ Track and Trace’ serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.
-
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs? ... drugs, whilst boosting generic drug prescription and supporting the domestic drug industry.
-
Exploring MINT: Part 1 - Mexico
middleman. Mexico’ s pharmaceutical regulator, COFEPRIS, has also implemented measures to improve transparency and has improved the conditions around intellectual property to eliminate ‘ similares’ - non bioequivalent ‘ copy’ drugs - from
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Featured jobs
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Senior Medical Writer
-
Salary is DOE
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
-
Sudler London - Account Director
-
Competitive
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
Subscribe to our email news alerts
- Tox trouble stalls Sosei/Allergan Alzheimer’s drug
- London cancer hub launched by Cancer Research UK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Making a Difference - The Future of Pharma
- AZ prepares to file COPD triple, taking on rival GSK
- Controversy grows around GP at Hand service after minister’s endorsement
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
